# A Novel Chronotype-Based Mediterranean Diet Pyramid: An Updated Representation by the Italian Society of Endocrinology (SIE) and the Italian Society of Dietetics and Clinical Nutrition (ADI)

**Authors:** Luigi Barrea, Ludovica Verde, Elisabetta Camajani, Giuseppe Annunziata, Maria Pina Mollica, Marianna Minnetti, Giovanna Trinchese, Pietro Losignore, Annamaria Colao, Alberto Ferlin, Carmela Bagnato, Diego Ferone, Barbara Paolini, Massimiliano Caprio, Giovanna Muscogiuri

PMC · DOI: 10.1007/s13668-026-00731-x · Current Nutrition Reports · 2026-02-13

## TL;DR

This paper introduces a new Mediterranean Diet pyramid that considers individual chronotypes and meal timing to improve metabolic health.

## Contribution

The novel contribution is a chronotype-based Mediterranean Diet pyramid integrating meal timing and circadian rhythms.

## Key findings

- Morning chronotypes adhere better to the Mediterranean Diet compared to evening chronotypes.
- Aligning meals with circadian rhythms improves glycemic control and cardiovascular outcomes.
- The proposed pyramid emphasizes early intake of carbohydrates and fiber, and evening intake of proteins and vegetables.

## Abstract

This review explores the integration of chronobiology and chronotype-specific factors into the Mediterranean Diet (MD) framework. While the MD is widely recognized for its cardiometabolic and neuroprotective effects, current guidelines do not address the timing of food intake or the influence of individual chronotype. Given the growing evidence linking circadian alignment, meal timing, and metabolic health, we propose a revised Mediterranean Diet pyramid tailored to chronotype and lifestyle determinants, herein referred to as the chronotype-based Mediterranean Diet Pyramid of the Italian Society of Endocrinology (SIE) and the Italian Society of Dietetics and Clinical Nutrition (ADI).

Chrononutrition emphasizes the timing, frequency, and regularity of meals as key elements for metabolic regulation. Early-day energy intake, time-restricted eating, and alignment with circadian rhythms improve glycemic control, weight management, and cardiovascular outcomes. Morning chronotypes tend to show higher adherence to the MD, whereas evening chronotypes more frequently delay meals, skip breakfast, and consume energy-dense foods at night, contributing to poorer metabolic profiles. Sleep duration and quality further modulate appetite regulation and dietary adherence. Building on these insights, the proposed pyramid integrates circadian cues, represented by sun and moon symbols, to guide nutrient timing. Foods rich in carbohydrates and fiber (whole grains, legumes, fruits) are emphasized earlier in the day, while protein- and vegetable-based meals are prioritized in the evening, alongside sleep-promoting foods such as dairy, nuts, and seeds. Lifestyle pillars, including physical activity, adequate sleep, and the alignment of eating schedules with chronotype, form the foundation of the pyramid.

The integration of chronobiological principles into the MD offers a novel paradigm that couples dietary quality with circadian alignment. A chronotype-oriented MD pyramid may enhance adherence, optimize metabolic flexibility, and reinforce the MD as a holistic model encompassing nutrition, lifestyle, and sustainability.

## Full-text entities

- **Genes:** NRF1 (nuclear respiratory factor 1) [NCBI Gene 4899] {aka ALPHA-PAL}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 8836] {aka GATD10, GH}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, PLIN1 (perilipin 1) [NCBI Gene 5346] {aka FPLD4, PERI, PLIN}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}, SST (somatostatin) [NCBI Gene 6750] {aka SMST, SST1}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** visceral adiposity (MESH:D007418), metabolic disease (MESH:D008659), non-communicable diseases (MESH:D000073296), overweight (MESH:D050177), stroke (MESH:D020521), fatigue (MESH:D005221), obese (MESH:D009765), circadian misalignment (MESH:D017760), weight gain (MESH:D015430), fatty liver disease (MESH:D005234), impaired glucose metabolism (MESH:D044882), neuroinflammation (MESH:D000090862), cancer (MESH:D009369), diabetes (MESH:D003920), insomnia (MESH:D007319), psychiatric (MESH:D001523), mitochondrial dysfunction (MESH:D028361), coronary heart disease (MESH:D003327), dyslipidemia (MESH:D050171), Sleep disturbances (MESH:D012893), metabolic syndrome (MESH:D024821), mitochondrial overload (MESH:D019190), sarcopenia (MESH:D055948), inflammation (MESH:D007249), neurodegenerative (MESH:D019636), hypertriglyceridemia (MESH:D015228), affective and cognitive disorders (MESH:D003072), lipid disturbances (MESH:D011017), sleep-disordered breathing (MESH:D012891), hyperuricemia (MESH:D033461), heart discomfort (MESH:D006331), disordered eating (MESH:D001068), muscle loss (MESH:D009135), adiposity (MESH:D018205), depression (MESH:D003866), hypercholesterolemia (MESH:D006937), T2D (MESH:D003924), insulin resistance (MESH:D007333), weight loss (MESH:D015431), gastrointestinal disorders (MESH:D005767), cardiovascular conditions (MESH:D002318), deaths (MESH:D003643), MD (MESH:D007161), GH resistance (MESH:D046150)
- **Chemicals:** Hydroxytyrosol (MESH:C005975), blood glucose (MESH:D001786), cholesterol (MESH:D002784), conjugated linoleic acid (MESH:D044243), resveratrol (MESH:D000077185), branched-chain amino acids (MESH:D000597), phenolic acids (MESH:C017616), Carotenoids (MESH:D002338), eicosapentaenoic acid (MESH:D015118), leucine (MESH:D007930), lycopene (MESH:D000077276), triglyceride (MESH:D014280), cortisol (MESH:D006854), histidine (MESH:D006639), Omega-3 fatty acids (MESH:D015525), fat (MESH:D005223), calcium (MESH:D002118), ROS (MESH:D017382), SCFAs (MESH:D005232), magnesium (MESH:D008274), glucose (MESH:D005947), serotonin (MESH:D012701), alcohol (MESH:D000438), tryptophan (MESH:D014364), NAD+ (MESH:D009243), Oleic acid (MESH:D019301), lysine (MESH:D008239), lipid (MESH:D008055), docosahexaenoic acid (MESH:D004281), Polyphenols (MESH:D059808), carbohydrate (MESH:D002241), arginine (MESH:D001120), SFAs (MESH:D005227), MUFAs (MESH:D005229), amino acid (MESH:D000596), butyrate (MESH:D002087), catecholamine (MESH:D002395), potassium (MESH:D011188), PUFAs (MESH:D005231), melatonin (MESH:D008550), olive oil (MESH:D000069463), EVOO (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** 995 A/T, rs1801260

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12904983/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12904983/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12904983/full.md

---
Source: https://tomesphere.com/paper/PMC12904983